Incyte - 33 Year Stock Price History | INCY

Historical daily share price chart and data for Incyte since 1993 adjusted for splits and dividends. The latest closing stock price for Incyte as of February 12, 2026 is 100.75.

The all-time high Incyte stock closing price was 152.66 on March 15, 2017.
The Incyte 52-week high stock price is 112.29, which is 11.5% above the current share price.
The Incyte 52-week low stock price is 53.56, which is 46.8% below the current share price.
The average Incyte stock price for the last 52 weeks is 81.12.

Incyte Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	103.7628	101.4200	110.5700	98.8400	100.7500	2.00%
2025	77.4525	69.5300	108.2600	55.1700	98.7700	43.00%
2024	62.9804	65.4500	83.3800	51.1800	69.0700	10.00%
2023	66.1166	79.5500	86.0100	52.1600	62.7900	-21.83%
2022	74.7658	73.9700	84.1100	66.0200	80.3200	9.43%
2021	77.9284	86.4500	100.5000	63.3400	73.4000	-15.61%
2020	88.8053	85.9700	109.6900	63.1800	86.9800	-0.39%
2019	81.9818	63.5600	95.7200	63.5600	87.3200	37.32%
2018	72.8748	100.8900	100.9800	58.5000	63.5900	-32.86%
2017	121.3776	102.3200	152.6600	93.5600	94.7100	-5.55%
2016	83.5443	103.3200	108.1000	63.0500	100.2700	-7.54%
2015	102.6877	73.7600	131.4700	71.4900	108.4500	48.34%
2014	57.1143	51.2300	78.8900	43.1000	73.1100	44.40%
2013	28.9761	17.0000	51.3400	17.0000	50.6300	204.82%
2012	19.2983	14.9900	25.8400	14.7800	16.6100	10.66%
2011	15.7089	16.5200	20.7600	11.7800	15.0100	-9.36%
2010	13.4671	9.5000	17.1700	9.4100	16.5600	81.78%
2009	4.7656	3.8500	9.4000	2.0500	9.1100	140.37%
2008	8.3997	9.9800	12.4200	2.4900	3.7900	-62.29%
2007	7.1488	6.0200	10.7800	4.8100	10.0500	72.09%
2006	4.8333	5.3400	6.2000	3.5800	5.8400	9.36%
2005	7.1163	9.6400	9.6600	4.2700	5.3400	-46.55%
2004	8.3024	6.8200	10.9600	5.4500	9.9900	46.05%
2003	4.6665	4.9090	6.9100	2.6700	6.8400	50.00%
2002	8.0164	19.4000	19.6900	2.9800	4.5600	-76.54%
2001	18.1807	22.5625	30.6250	10.7600	19.4400	-21.85%
2000	47.9742	44.8281	140.2500	23.5625	24.8750	-17.08%
1999	12.9276	18.5000	31.5625	8.2813	30.0000	60.54%
1998	17.8034	21.3750	25.1875	9.2500	18.6875	-16.94%
1997	16.6613	12.7500	22.5000	10.6250	22.5000	74.76%
1996	9.3198	7.0313	12.8750	6.0625	12.8750	106.00%
1995	4.4126	3.4063	6.2500	3.2813	6.2500	80.18%
1994	2.4208	2.1875	3.9063	1.7188	3.4688	54.17%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$19.671B	$5.141B
Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2 inhibitor, approved in the United States for the treatment of patients with polycythemia vera ('PV'),who have had an inadequate response to or are intolerant to hydroxyurea. It is also approved for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-PV MF, and post-essential thrombocythemia MF. The drug is also approved in the United States for treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients aged 12 years or older.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$317.564B	25.28
Amgen (AMGN)	United States	$197.396B	16.78
Gilead Sciences (GILD)	United States	$193.298B	19.12
Bristol Myers Squibb (BMY)	United States	$122.003B	9.74
GSK (GSK)	United Kingdom	$119.226B	12.94
Vertex Pharmaceuticals (VRTX)	United States	$117.025B	30.13
Regeneron Pharmaceuticals (REGN)	United States	$81.869B	21.59
CSL (CSLLY)	Australia	$55.133B	0.00
Argenex SE (ARGX)	Netherlands	$51.645B	63.80
Alnylam Pharmaceuticals (ALNY)	United States	$42.578B	1401.22
Insmed (INSM)	United States	$31.656B	0.00
Biogen (BIIB)	United States	$28.060B	12.51
Royalty Pharma (RPRX)	United States	$25.543B	9.16
BioNTech SE (BNTX)	Germany	$24.630B	0.00
Exact Sciences (EXAS)	United States	$19.736B	544.37
Genmab (GMAB)	Denmark	$19.310B	14.52
Revolution Medicines (RVMD)	United States	$18.943B	0.00
Roivant Sciences (ROIV)	United Kingdom	$18.639B	0.00
Illumina (ILMN)	United States	$17.783B	24.00
Moderna (MRNA)	United States	$15.829B	0.00
Sino Biopharmaceutical (SBMFF)	Hong Kong, SAR China	$14.594B	0.00
Ascendis Pharma (ASND)	Denmark	$13.727B	0.00
Guardant Health (GH)	United States	$13.560B	0.00
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$13.213B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	21.26
BioMarin Pharmaceutical (BMRN)	United States	$11.586B	21.01
Avidity Biosciences (RNA)	United States	$11.284B	0.00
Exelixis (EXEL)	United States	$11.152B	15.73
QIAGEN (QGEN)	Netherlands	$10.783B	20.65
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.102B	39.39
Bio-Techne Corp (TECH)	United States	$9.927B	36.05
Abivax SA (ABVX)	France	$9.631B	0.00
Axsome Therapeutics (AXSM)	United States	$9.387B	0.00
Halozyme Therapeutics (HALO)	United States	$9.350B	14.94
Arrowhead Pharmaceuticals (ARWR)	United States	$8.619B	40.23
Cytokinetics (CYTK)	United States	$8.167B	0.00
Praxis Precision Medicines (PRAX)	United States	$8.145B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$7.959B	28.62
Krystal Biotech (KRYS)	United States	$7.906B	40.88
Repligen (RGEN)	United States	$7.847B	83.98
Nuvalent (NUVL)	United States	$7.500B	0.00
Vaxcyte (PCVX)	United States	$7.246B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.572B	0.00
Belite Bio (BLTE)	United States	$6.567B	0.00
ImmunityBio (IBRX)	United States	$6.442B	0.00
Kymera Therapeutics (KYMR)	United States	$5.919B	0.00
Alkermes (ALKS)	Ireland	$5.764B	16.95
PTC Therapeutics (PTCT)	United States	$5.694B	7.73
Cogent Biosciences (COGT)	United States	$5.296B	0.00
Immunovant (IMVT)	United States	$5.280B	0.00
Protagonist Therapeutics (PTGX)	United States	$5.219B	134.66
Mirum Pharmaceuticals (MIRM)	United States	$5.133B	0.00
Celcuity (CELC)	United States	$4.823B	0.00
Scholar Rock Holding (SRRK)	United States	$4.809B	0.00
Structure Therapeutics (GPCR)	United States	$4.610B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$4.605B	0.00
TG Therapeutics (TGTX)	United States	$4.575B	10.37
Zealand Pharma (ZLDPF)	Denmark	$4.534B	4.59
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Apogee Therapeutics (APGE)	United States	$4.496B	0.00
Amicus Therapeutics (FOLD)	United States	$4.492B	357.75
CG Oncology (CGON)	United States	$4.320B	0.00
Arcellx (ACLX)	United States	$4.041B	0.00
GRAIL (GRAL)	United States	$3.914B	0.00
Anbio Biotechnology (NNNN)	Germany	$3.908B	0.00
ADMA Biologics Inc (ADMA)	United States	$3.875B	27.59
ACADIA Pharmaceuticals (ACAD)	United States	$3.802B	32.10
Ligand Pharmaceuticals (LGND)	United States	$3.660B	89.84
Erasca (ERAS)	United States	$3.579B	0.00
Liquidia (LQDA)	United States	$3.495B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.481B	0.00
Legend Biotech (LEGN)	United States	$3.424B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.409B	99.96
Xenon Pharmaceuticals (XENE)	Canada	$3.304B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.257B	0.00
Edgewise Therapeutics (EWTX)	United States	$3.246B	0.00
Viking Therapeutics (VKTX)	United States	$3.227B	0.00
Twist Bioscience (TWST)	United States	$3.044B	0.00
Denali Therapeutics (DNLI)	United States	$2.888B	0.00
Viridian Therapeutics (VRDN)	United States	$2.870B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.823B	71.97
IDEAYA Biosciences (IDYA)	United States	$2.797B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$2.776B	0.00
Vera Therapeutics (VERA)	United States	$2.746B	0.00
Disc Medicine (IRON)	United States	$2.718B	0.00
Travere Therapeutics (TVTX)	United States	$2.704B	0.00
Alumis (ALMS)	United States	$2.676B	0.00
Beam Therapeutics (BEAM)	United States	$2.637B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.636B	0.00
Spyre Therapeutics (SYRE)	United States	$2.632B	0.00
Immunome (IMNM)	United States	$2.583B	0.00
Adaptive Biotechnologies (ADPT)	United States	$2.385B	0.00
Mesoblast (MESO)	Australia	$2.361B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.357B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.351B	6.38
Telix Pharmaceuticals (TLX)	Australia	$2.348B	0.00
Arcus Biosciences (RCUS)	United States	$2.306B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.304B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.296B	0.00
Maze Therapeutics (MAZE)	United States	$2.272B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.219B	0.00
Dianthus Therapeutics (DNTH)	United States	$2.158B	0.00
Zai Lab (ZLAB)	China	$2.131B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.107B	11.51
Nuvation Bio (NUVB)	United States	$1.961B	0.00
Recursion Pharmaceuticals (RXRX)	United States	$1.929B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.887B	0.00
Sarepta Therapeutics (SRPT)	United States	$1.882B	0.00
Stoke Therapeutics (STOK)	United States	$1.840B	48.09
Dynavax Technologies (DVAX)	United States	$1.819B	53.41
MannKind (MNKD)	United States	$1.763B	57.40
Vericel (VCEL)	United States	$1.751B	144.29
Precigen (PGEN)	United States	$1.737B	0.00
ANI Pharmaceuticals (ANIP)	United States	$1.713B	13.28
Zymeworks (ZYME)	United States	$1.709B	0.00
Tango Therapeutics (TNGX)	United States	$1.698B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.664B	0.00
Nurix Therapeutics (NRIX)	United States	$1.657B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$1.654B	0.00
Celldex Therapeutics (CLDX)	United States	$1.635B	0.00
Sionna Therapeutics (SION)	United States	$1.630B	0.00
Olema Pharmaceuticals (OLMA)	United States	$1.624B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.616B	0.00
Tyra Biosciences (TYRA)	United States	$1.601B	0.00
Rapt Therapeutics (RAPT)	United States	$1.599B	0.00
MBX Biosciences (MBX)	United States	$1.572B	0.00
AnaptysBio (ANAB)	United States	$1.530B	0.00
UniQure (QURE)	Netherlands	$1.502B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.497B	0.00
NeoGenomics (NEO)	United States	$1.481B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
Alvotech (ALVO)	Luxembourg	$1.462B	21.09
Novavax (NVAX)	United States	$1.458B	3.71
AtaiBeckley Inc (ATAI)	Netherlands	$1.442B	0.00
Trevi Therapeutics (TRVI)	United States	$1.417B	0.00
Intellia Therapeutics (NTLA)	United States	$1.390B	0.00
Rapport Therapeutics (RAPP)	United States	$1.317B	0.00
Zenas BioPharma (ZBIO)	United States	$1.249B	0.00
Biohaven (BHVN)	United States	$1.247B	0.00
Immatics (IMTX)	Germany	$1.246B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.235B	59.25
Kodiak Sciences (KOD)	United States	$1.215B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.202B	0.00
Inhibrx Biosciences (INBX)	United States	$1.192B	0.00
Septerna (SEPN)	United States	$1.179B	0.00
NovoCure (NVCR)	Jersey	$1.176B	0.00
Nanobiotix S.A - (NBTX)	France	$1.167B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$1.153B	0.00
Compass Therapeutics (CMPX)	United States	$1.145B	0.00
Certara (CERT)	United States	$1.104B	20.38
Pharming Group (PHAR)	Netherlands	$1.092B	0.00
Fortrea Holdings (FTRE)	United States	$1.071B	22.73
EyePoint (EYPT)	United States	$1.064B	0.00
Sana Biotechnology (SANA)	United States	$1.034B	0.00
Vir Biotechnology (VIR)	United States	$1.032B	0.00
Iovance Biotherapeutics (IOVA)	United States	$1.032B	0.00
Geron (GERN)	United States	$1.028B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.014B	0.00
Ventyx Biosciences (VTYX)	United States	$1.000B	0.00
Oric Pharmaceuticals (ORIC)	United States	$0.993B	0.00
Urogen Pharma (URGN)	United States	$0.990B	0.00
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.963B	0.00
Castle Biosciences (CSTL)	United States	$0.944B	129.36
CytomX Therapeutics (CTMX)	United States	$0.942B	13.90
AbCellera Biologics (ABCL)	Canada	$0.937B	0.00
Palvella Therapeutics (PVLA)	United States	$0.937B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.935B	0.00
Pacira BioSciences (PCRX)	United States	$0.935B	10.70
CureVac (CVAC)	Germany	$0.927B	0.00
DBV Technologies S.A (DBVT)	France	$0.908B	0.00
Inventiva S.A (IVA)	France	$0.903B	0.00
Evommune (EVMN)	United States	$0.897B	0.00
ArriVent BioPharma (AVBP)	United States	$0.893B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$0.873B	0.00
Arvinas (ARVN)	United States	$0.841B	0.00
Bicara Therapeutics (BCAX)	United States	$0.811B	0.00
MapLight Therapeutics (MPLT)	United States	$0.806B	0.00
Arbutus Biopharma (ABUS)	United States	$0.800B	0.00
Upstream Bio (UPB)	United States	$0.794B	0.00
Janux Therapeutics (JANX)	United States	$0.789B	0.00
GH Research (GHRS)	Ireland	$0.788B	0.00
YD Bio (YDES)		$0.779B	0.00
MiMedx (MDXG)	United States	$0.772B	13.71
Bright Minds Biosciences (DRUG)	United States	$0.758B	0.00
Gyre Therapeutics (GYRE)	United States	$0.756B	98.12
Jade Biosciences (JBIO)	United States	$0.743B	0.00
Astria Therapeutics (ATXS)	United States	$0.718B	0.00
BioAge Labs (BIOA)	United States	$0.717B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.707B	0.00
Kura Oncology (KURA)	United States	$0.682B	0.00
EnGene Holdings (ENGN)	Canada	$0.664B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Replimune (REPL)	United States	$0.641B	0.00
Annexon (ANNX)	United States	$0.627B	0.00
Prime Medicine (PRME)	United States	$0.623B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.609B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.600B	0.00
Design Therapeutics (DSGN)	United States	$0.590B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.588B	0.00
CorMedix Inc (CRMD)	United States	$0.585B	5.42
Emergent Biosolutions (EBS)	United States	$0.579B	5.57
Ginkgo Bioworks Holdings (DNA)	United States	$0.567B	0.00
Cytek Biosciences (CTKB)	United States	$0.557B	0.00
Gossamer Bio (GOSS)	United States	$0.544B	0.00
SELLAS Life Sciences (SLS)	United States	$0.523B	0.00
Keros Therapeutics (KROS)	United States	$0.519B	11.06
Alto Neuroscience (ANRO)	United States	$0.519B	0.00
Neumora Therapeutics (NMRA)	United States	$0.501B	0.00
Solid Biosciences (SLDB)	United States	$0.499B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.498B	0.00
Kamada (KMDA)	Israel	$0.489B	23.64
ADC Therapeutics SA (ADCT)	Switzerland	$0.486B	0.00
Prothena (PRTA)	Ireland	$0.481B	0.00
Myriad Genetics (MYGN)	United States	$0.452B	0.00
Contineum Therapeutics (CTNM)	United States	$0.445B	0.00
Ocugen (OCGN)	United States	$0.440B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.439B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.432B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.430B	0.00
REGENXBIO (RGNX)	United States	$0.430B	0.00
Verastem (VSTM)	United States	$0.423B	0.00
Entrada Therapeutics (TRDA)	United States	$0.423B	0.00
LENZ Therapeutics (LENZ)	United States	$0.423B	0.00
PureTech Health (PRTC)	United States	$0.422B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.414B	0.00
Tectonic Therapeutic (TECX)	United States	$0.412B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.411B	0.00
Prima BioMed (IMMP)	Australia	$0.411B	0.00
Niagen Bioscience (NAGE)	United States	$0.408B	31.94
Zura Bio (ZURA)	United States	$0.407B	0.00
GENFIT S.A (GNFTY)	France	$0.400B	0.00
Benitec Biopharma (BNTC)	United States	$0.399B	0.00
Monopar Therapeutics (MNPR)	United States	$0.397B	0.00
PepGen (PEPG)	United States	$0.394B	0.00
Absci (ABSI)	United States	$0.391B	0.00
NovaBridge Biosciences (NBP)	United States	$0.391B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.384B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.384B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.381B	0.00
Climb Bio (CLYM)	United States	$0.379B	0.00
Invivyd (IVVD)	United States	$0.375B	0.00
Forte Biosciences (FBRX)	United States	$0.374B	0.00
Allogene Therapeutics (ALLO)	United States	$0.371B	0.00
Immix Biopharma (IMMX)	United States	$0.362B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.360B	0.00
Anavex Life Sciences (AVXL)	United States	$0.360B	0.00
Aura Biosciences (AURA)	United States	$0.357B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.351B	0.00
Atea Pharmaceuticals (AVIR)	United States	$0.348B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.343B	0.00
Puma Biotechnology (PBYI)	United States	$0.335B	8.97
Kyverna Therapeutics (KYTX)	United States	$0.331B	0.00
Immuneering (IMRX)	United States	$0.326B	0.00
Amarin (AMRN)	Ireland	$0.314B	0.00
Rezolute (RZLT)	United States	$0.312B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.307B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.305B	0.00
AC Immune (ACIU)	Switzerland	$0.304B	0.00
Candel Therapeutics (CADL)	United States	$0.304B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.300B	0.00
XOMA Royalty (XOMA)	United States	$0.288B	0.00
Aardvark Therapeutics (AARD)	United States	$0.276B	0.00
Abeona Therapeutics (ABEO)	United States	$0.274B	4.48
Nautilus Biotechnology (NAUT)	United States	$0.273B	0.00
Lifecore Biomedical (LFCR)	United States	$0.271B	0.00
Adherex Technologies (FENC)	United States	$0.268B	0.00
Neurogene (NGNE)	United States	$0.262B	0.00
Palisade Bio (PALI)	United States	$0.259B	0.00
Shattuck Labs (STTK)	United States	$0.259B	0.00
Cabaletta Bio (CABA)	United States	$0.247B	0.00
Coherus Oncology (CHRS)	United States	$0.247B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.229B	0.00
Opus Genetics (IRD)	United States	$0.227B	0.00
Nuvectis Pharma (NVCT)	United States	$0.225B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.219B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.210B	0.00
Alector (ALEC)	United States	$0.210B	0.00
Voyager Therapeutics (VYGR)	United States	$0.203B	0.00
SAB Biotherapeutics (SABS)	United States	$0.199B	0.00
Humacyte (HUMA)	United States	$0.189B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.188B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.180B	0.00
Satellos Bioscience (MSLE)	Canada	$0.180B	0.00
C4 Therapeutics (CCCC)	United States	$0.177B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.177B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.176B	0.00
Editas Medicine (EDIT)	United States	$0.173B	0.00
Sagimet Biosciences (SGMT)	United States	$0.171B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.166B	0.00
Tharimmune (THAR)	United States	$0.164B	0.00
Innate Pharma S.A (IPHA)	France	$0.159B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.157B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.155B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.155B	0.00
Alps Group (ALPS)	United States	$0.155B	2.82
Connect Biopharma Holdings (CNTB)	United States	$0.150B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.149B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.149B	0.00
Caribou Biosciences (CRBU)	United States	$0.149B	0.00
Anika Therapeutics (ANIK)	United States	$0.148B	0.00
Elicio Therapeutics (ELTX)	United States	$0.147B	0.00
Adagene (ADAG)	China	$0.146B	0.00
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Nkarta (NKTX)	United States	$0.142B	0.00
Vor Biopharma (VOR)		$0.139B	0.00
VTv Therapeutics (VTVT)	United States	$0.135B	0.00
Fate Therapeutics (FATE)	United States	$0.135B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.134B	0.00
Sutro Biopharma (STRO)	United States	$0.134B	0.00
Spero Therapeutics (SPRO)	United States	$0.134B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.133B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.132B	0.00
Crescent Biopharma (CBIO)	United States	$0.131B	0.00
Seres Therapeutics (MCRB)	United States	$0.127B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.126B	6.17
Eledon Pharmaceuticals (ELDN)	United States	$0.121B	0.00
BGM Group (BGM)	China	$0.115B	0.00
Repare Therapeutics (RPTX)	Canada	$0.114B	0.00
Fortress Biotech (FBIO)	United States	$0.114B	0.00
Alpha Cognition (ACOG)	Canada	$0.113B	0.00
Ovid Therapeutics (OVID)	United States	$0.113B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.113B	0.00
Alpha Teknova (TKNO)	United States	$0.113B	0.00
Jyong Biotech (MENS)	Taiwan	$0.111B	0.00
Cardiff Oncology (CRDF)	United States	$0.108B	0.00
Codexis (CDXS)	United States	$0.107B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.107B	0.00
Seer (SEER)	United States	$0.107B	0.00
Turn Therapeutics (TTRX)	United States	$0.106B	0.00
Coya Therapeutics (COYA)	United States	$0.103B	0.00
Agenus (AGEN)	United States	$0.101B	0.00
Citius Oncology (CTOR)	United States	$0.100B	0.00
Actuate Therapeutics (ACTU)	United States	$0.098B	0.00
Cognition Therapeutics (CGTX)	United States	$0.097B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.095B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.095B	0.00
Equillium (EQ)	United States	$0.094B	0.00
Precision BioSciences (DTIL)	United States	$0.093B	0.00
Biomea Fusion (BMEA)	United States	$0.093B	0.00
BioStem Technologies (BSEM)		$0.093B	6.47
Genelux (GNLX)	United States	$0.092B	0.00
ATyr Pharma (ATYR)	United States	$0.091B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.091B	0.00
Immunic (IMUX)	United States	$0.089B	0.00
Spruce Biosciences (SPRB)	United States	$0.089B	0.00
EXoZymes (EXOZ)	United States	$0.084B	0.00
Tenax Therapeutics (TENX)	United States	$0.081B	0.00
BioHarvest Sciences (BHST)	Canada	$0.080B	0.00
ImageneBio (IMA)	United States	$0.079B	0.00
TuHURA Biosciences (HURA)	United States	$0.078B	0.00
MediciNova (MNOV)	United States	$0.078B	0.00
MaxCyte (MXCT)	United States	$0.078B	0.00
IBio (IBIO)	United States	$0.076B	0.00
Entera Bio (ENTX)	Israel	$0.075B	0.00
OKYO Pharma (OKYO)		$0.073B	0.00
Scilex Holding (SCLX)	United States	$0.073B	0.00
XBiotech (XBIT)	United States	$0.072B	0.00
Pliant Therapeutics (PLRX)	United States	$0.071B	0.00
Adicet Bio (ACET)	United States	$0.065B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.064B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.063B	0.00
Annovis Bio (ANVS)	United States	$0.063B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.060B	0.00
BeyondSpring (BYSI)	United States	$0.057B	0.00
InflaRx (IFRX)	Germany	$0.057B	0.00
Grace Therapeutics (GRCE)	United States	$0.056B	0.00
TScan Therapeutics (TCRX)	United States	$0.055B	0.00
Instil Bio (TIL)	United States	$0.053B	0.00
MiNK Therapeutics (INKT)	United States	$0.052B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.051B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.049B	0.00
Estrella Immunopharma (ESLA)	United States	$0.049B	0.00
Cingulate (CING)	United States	$0.049B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.048B	0.00
Kezar Life Sciences (KZR)	United States	$0.046B	0.00
Aligos Therapeutics (ALGS)	United States	$0.046B	0.00
Clene (CLNN)	United States	$0.045B	0.00
CervoMed (CRVO)	United States	$0.044B	0.00
ABVC BioPharma (ABVC)	United States	$0.044B	0.00
NextCure (NXTC)	United States	$0.044B	0.00
Q32 Bio (QTTB)	United States	$0.043B	0.00
INmune Bio (INMB)	United States	$0.042B	0.00
Lisata Therapeutics (LSTA)	United States	$0.040B	0.00
Elutia (ELUT)	United States	$0.038B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
Pluri (PLUR)	Israel	$0.037B	0.00
Xilio Therapeutics (XLO)	United States	$0.036B	0.00
Celularity (CELU)	United States	$0.036B	0.00
RenovoRx (RNXT)	United States	$0.036B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.035B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.035B	0.00
PDS Biotechnology (PDSB)	United States	$0.035B	0.00
Galecto (GLTO)	Denmark	$0.035B	0.00
Jasper Therapeutics (JSPR)	United States	$0.035B	0.00
Oncobiologics (OTLK)	United States	$0.035B	0.00
Quince Therapeutics (QNCX)	United States	$0.034B	0.00
OnKure Therapeutics (OKUR)	United States	$0.033B	0.00
TELA Bio (TELA)	United States	$0.033B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.033B	2.11
Hyperion DeFi (HYPD)	United States	$0.033B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.033B	0.00
Lantern Pharma (LTRN)	United States	$0.032B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.032B	0.00
Promis Neurosciences (PMN)	Canada	$0.031B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.031B	0.00
Rein Therapeutics (RNTX)	United States	$0.031B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.031B	0.00
AN2 Therapeutics (ANTX)	United States	$0.030B	0.00
Femasys (FEMY)	United States	$0.030B	0.00
Dyadic (DYAI)	United States	$0.029B	0.00
Passage Bio (PASG)	United States	$0.028B	0.00
Exicure (XCUR)	United States	$0.027B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
IO Biotech (IOBT)	Denmark	$0.026B	0.00
Cue Biopharma (CUE)	United States	$0.025B	0.00
Rallybio (RLYB)	United States	$0.025B	0.00
Boundless Bio (BOLD)	United States	$0.025B	0.00
Dare Bioscience (DARE)	United States	$0.025B	0.00
Aytu BioPharma (AYTU)	United States	$0.024B	0.00
Medicus Pharma (MDCX)	United States	$0.024B	0.00
Skye Bioscience (SKYE)	United States	$0.023B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.023B	0.00
Senti Biosciences (SNTI)	United States	$0.023B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.023B	0.00
Intensity Therapeutics (INTS)	United States	$0.022B	0.00
Apollomics (APLM)	United States	$0.022B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.022B	0.00
LeonaBio (LONA)	United States	$0.020B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.020B	0.00
IN8bio (INAB)	United States	$0.019B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.017B	0.00
FibroBiologics (FBLG)	United States	$0.017B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.017B	0.00
Black Titan (BTTC)	United States	$0.016B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.016B	0.00
Quantum Biopharma (QNTM)	Canada	$0.015B	0.00
Curis (CRIS)	United States	$0.015B	0.00
Allarity Therapeutics (ALLR)	United States	$0.014B	0.00
Hoth Therapeutics (HOTH)	United States	$0.014B	0.00
Applied Therapeutics (APLT)	United States	$0.014B	0.00
Polyrizon (PLRZ)	Israel	$0.013B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.013B	0.00
Cocrystal Pharma (COCP)	United States	$0.013B	0.00
NewcelX (NCEL)	Switzerland	$0.013B	0.00
BioCardia (BCDA)	United States	$0.013B	0.00
BioAtla (BCAB)	United States	$0.012B	0.00
Bionano Genomics (BNGO)	United States	$0.012B	0.00
Longeveron (LGVN)	United States	$0.012B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.011B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.011B	0.00
Soligenix (SNGX)	United States	$0.011B	0.00
Imunon (IMNN)	United States	$0.011B	0.00
Revelation Biosciences (REVB)	United States	$0.010B	0.00
CalciMedica (CALC)	United States	$0.010B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.010B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.010B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.009B	0.00
Biofrontera (BFRI)	United States	$0.009B	0.00
Edesa Biotech (EDSA)	Canada	$0.009B	0.00
Novogen (KZIA)	Australia	$0.009B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.009B	0.00
Moleculin Biotech (MBRX)	United States	$0.009B	0.00
Beyond Air (XAIR)	United States	$0.008B	0.00
Mainz Biomed (MYNZ)	Germany	$0.008B	0.00
Purple Biotech (PPBT)	Israel	$0.008B	0.00
Gelteq (GELS)	Australia	$0.007B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.007B	0.00
Aptevo Therapeutics (APVO)	United States	$0.007B	0.00
GENPREX (GNPX)	United States	$0.007B	0.00
Alzamend Neuro (ALZN)	United States	$0.007B	0.00
Mustang Bio (MBIO)	United States	$0.007B	0.00
IMMURON (IMRN)	Australia	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
Evogene (EVGN)	Israel	$0.005B	0.00
Advanced Biomed (ADVB)	United States	$0.005B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.005B	0.00
GT Biopharma (GTBP)	United States	$0.005B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.005B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.005B	0.00
BioAffinity Technologies (BIAF)	United States	$0.004B	0.00
GeoVax Labs (GOVX)	United States	$0.004B	0.00
Aprea Therapeutics (APRE)	United States	$0.004B	0.00
Dermata Therapeutics (DRMA)	United States	$0.004B	0.00
KALA BIO (KALA)	United States	$0.004B	0.00
Silo Pharma (SILO)	United States	$0.004B	0.00
Biorestorative Therapies (BRTX)	United States	$0.004B	0.00
MetaVia (MTVA)	United States	$0.004B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.004B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.004B	0.00
Avalon GloboCare (ALBT)	United States	$0.004B	0.00
Abpro Holdings (ABP)	United States	$0.003B	0.00
GRI Bio (GRI)	United States	$0.003B	0.00
AquaBounty Technologies (AQB)	United States	$0.003B	0.00
HCW Biologics (HCWB)	United States	$0.003B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.003B	0.00
Psyence Biomedical (PBM)	Canada	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Onconetix (ONCO)	United States	$0.003B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.003B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.002B	0.00
Bone Biologics (BBLG)	United States	$0.002B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.002B	0.00
Ensysce Biosciences (ENSC)	United States	$0.001B	0.00
Enveric Biosciences (ENVB)	United States	$0.001B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Compugen (CGEN)	Israel	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pharvaris (PHVS)	Netherlands	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00